<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03240097</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-15T22:28:04+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">The Normal and Brain Tumor Vasculature: Morphological and Functional Characteristics and Therapeutic Targeting</title>
            <author role="aut">
              <persName>
                <forename type="first">Joris</forename>
                <surname>Guyon</surname>
              </persName>
              <email type="md5">b9a7f6fa2f5aff139185afc77a3c8d9c</email>
              <email type="domain">u-bordeaux.fr</email>
              <idno type="idhal" notation="string">joris-guyon</idno>
              <idno type="idhal" notation="numeric">739119</idno>
              <idno type="halauthorid" notation="string">46898-739119</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-6692-2890</idno>
              <idno type="IDREF">https://www.idref.fr/260163627</idno>
              <affiliation ref="#struct-214114"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Candice</forename>
                <surname>Chapouly</surname>
              </persName>
              <idno type="idhal" notation="numeric">768111</idno>
              <idno type="halauthorid" notation="string">697130-768111</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-9173-1615</idno>
              <idno type="IDREF">https://www.idref.fr/169798844</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Laetitia</forename>
                <surname>Andrique</surname>
              </persName>
              <email type="md5">709779f33c9105c5c1db56a8ed325a07</email>
              <email type="domain">u-bordeaux.fr</email>
              <idno type="idhal" notation="string">landrique</idno>
              <idno type="idhal" notation="numeric">1627675</idno>
              <idno type="halauthorid" notation="string">2217118-1627675</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-7840-8135</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Andreas</forename>
                <surname>Bikfalvi</surname>
              </persName>
              <idno type="idhal" notation="numeric">759771</idno>
              <idno type="halauthorid" notation="string">313149-759771</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-4138-5229</idno>
              <affiliation ref="#struct-214114"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Thomas</forename>
                <surname>Daubon</surname>
              </persName>
              <email type="md5">8d425d3b69ad3556b6e3194a7f33b1b6</email>
              <email type="domain">u-bordeaux.fr</email>
              <idno type="idhal" notation="string">thomas-daubon</idno>
              <idno type="idhal" notation="numeric">737075</idno>
              <idno type="halauthorid" notation="string">2809-737075</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-0319-7617</idno>
              <idno type="IDREF">https://www.idref.fr/135422906</idno>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Thomas</forename>
                <surname>DAUBON</surname>
              </persName>
              <email type="md5">8d425d3b69ad3556b6e3194a7f33b1b6</email>
              <email type="domain">u-bordeaux.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2024-11-12 15:40:12</date>
              <date type="whenModified">2025-12-30 12:06:34</date>
              <date type="whenReleased">2024-11-15 11:06:54</date>
              <date type="whenProduced">2021-03-05</date>
              <date type="whenEndEmbargoed">2024-11-12</date>
              <ref type="file" target="https://hal.science/hal-03240097v1/document">
                <date notBefore="2024-11-12"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://hal.science/hal-03240097v1/file/main.pdf" id="file-4778142-4160568">
                <date notBefore="2024-11-12"/>
              </ref>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973205"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="558664">
                <persName>
                  <forename>Thomas</forename>
                  <surname>DAUBON</surname>
                </persName>
                <email type="md5">8d425d3b69ad3556b6e3194a7f33b1b6</email>
                <email type="domain">u-bordeaux.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03240097</idno>
            <idno type="halUri">https://hal.science/hal-03240097</idno>
            <idno type="halBibtex">guyon:hal-03240097</idno>
            <idno type="halRefHtml">&lt;i&gt;Frontiers in Physiology&lt;/i&gt;, 2021, 12, &lt;a target="_blank" href="https://dx.doi.org/10.3389/fphys.2021.622615"&gt;&amp;#x27E8;10.3389/fphys.2021.622615&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Frontiers in Physiology, 2021, 12, &amp;#x27E8;10.3389/fphys.2021.622615&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-4778142-4160568"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt/>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">The Normal and Brain Tumor Vasculature: Morphological and Functional Characteristics and Therapeutic Targeting</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Joris</forename>
                    <surname>Guyon</surname>
                  </persName>
                  <email type="md5">b9a7f6fa2f5aff139185afc77a3c8d9c</email>
                  <email type="domain">u-bordeaux.fr</email>
                  <idno type="idhal" notation="string">joris-guyon</idno>
                  <idno type="idhal" notation="numeric">739119</idno>
                  <idno type="halauthorid" notation="string">46898-739119</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-6692-2890</idno>
                  <idno type="IDREF">https://www.idref.fr/260163627</idno>
                  <affiliation ref="#struct-214114"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Candice</forename>
                    <surname>Chapouly</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">768111</idno>
                  <idno type="halauthorid" notation="string">697130-768111</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-9173-1615</idno>
                  <idno type="IDREF">https://www.idref.fr/169798844</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Laetitia</forename>
                    <surname>Andrique</surname>
                  </persName>
                  <email type="md5">709779f33c9105c5c1db56a8ed325a07</email>
                  <email type="domain">u-bordeaux.fr</email>
                  <idno type="idhal" notation="string">landrique</idno>
                  <idno type="idhal" notation="numeric">1627675</idno>
                  <idno type="halauthorid" notation="string">2217118-1627675</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-7840-8135</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Andreas</forename>
                    <surname>Bikfalvi</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">759771</idno>
                  <idno type="halauthorid" notation="string">313149-759771</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-4138-5229</idno>
                  <affiliation ref="#struct-214114"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Thomas</forename>
                    <surname>Daubon</surname>
                  </persName>
                  <email type="md5">8d425d3b69ad3556b6e3194a7f33b1b6</email>
                  <email type="domain">u-bordeaux.fr</email>
                  <idno type="idhal" notation="string">thomas-daubon</idno>
                  <idno type="idhal" notation="numeric">737075</idno>
                  <idno type="halauthorid" notation="string">2809-737075</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-0319-7617</idno>
                  <idno type="IDREF">https://www.idref.fr/135422906</idno>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">82422</idno>
                <idno type="issn">1664-042X</idno>
                <title level="j">Frontiers in Physiology</title>
                <imprint>
                  <publisher>Frontiers</publisher>
                  <biblScope unit="volume">12</biblScope>
                  <date type="datePub">2021-03-05</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3389/fphys.2021.622615</idno>
              <idno type="pubmedcentral">PMC7973205</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halDomain" n="sdv.sp">Life Sciences [q-bio]/Pharmaceutical sciences</classCode>
              <classCode scheme="halDomain" n="sdv.bc">Life Sciences [q-bio]/Cellular Biology</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Glioblastoma is among the most common tumor of the central nervous system in adults. Overall survival has not significantly improved over the last decade, even with optimizing standard therapeutic care including extent of resection and radio- and chemotherapy. In this article, we review features of the brain vasculature found in healthy cerebral tissue and in glioblastoma. Brain vessels are of various sizes and composed of several vascular cell types. Non-vascular cells such as astrocytes or microglia also interact with the vasculature and play important roles. We also discuss in vitro engineered artificial blood vessels which may represent useful models for better understanding the tumor–vessel interaction. Finally, we summarize results from clinical trials with anti-angiogenic therapy alone or in combination, and discuss the value of these approaches for targeting glioblastoma.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-214114" status="VALID">
          <orgName>Laboratoire Angiogenèse et Micro-environnement des Cancers</orgName>
          <orgName type="acronym">LAMC</orgName>
          <desc>
            <address>
              <addrLine>Faculté des Sciences - Avenue des Facultés 33405 Talence Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u1029.u-bordeaux1.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-92972" type="direct"/>
            <relation name="U1029" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-92972" status="VALID">
          <orgName>Université Sciences et Technologies - Bordeaux 1</orgName>
          <orgName type="acronym">UB</orgName>
          <date type="start">1971-01-01</date>
          <date type="end">2013-12-31</date>
          <desc>
            <address>
              <addrLine>351 cours de la Libération - 33405 Talence.</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u-bordeaux1.fr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>